interferoninduc
ubiquitinlik
protein
conjug
target
protein
via
sequenti
action
three
enzym
also
induc
interferon
unlik
ubiquitin
highli
conserv
sequenc
vari
speci
conjug
inhibit
mani
virus
free
unconjug
also
act
antivir
protein
focu
antivir
role
conjug
countermeasur
employ
sever
virus
countermeasur
influenza
b
viru
uniqu
exhibit
speciesspecif
antivir
activ
human
nonhuman
primat
block
provid
one
possibl
explan
restrict
influenza
b
viru
human
interferon
influenza
b
viru
protein
speciesspecif
ovarian
tumor
domain
antivir
role
pathway
major
respons
mammalian
cell
viru
infect
product
turn
induc
synthesi
larg
number
protein
mani
antivir
activ
virus
counter
antivir
respons
inhibit
product
andor
block
antivir
action
ifninduc
protein
one
highli
induc
ifninduc
protein
ubiquitinlik
ubl
protein
compris
two
ubl
domain
connect
short
acid
linker
ntermin
ctermin
ubl
domain
ident
ubiquitin
ub
respect
unlik
ub
highli
conserv
sequenc
vari
speci
coval
attach
target
protein
ctermin
lrlrgg
sequenc
via
sequenti
action
three
enzym
also
induc
activ
enzym
conjug
enzym
major
ligas
also
induc
enzym
remov
protein
intriguingli
exist
mice
whose
major
ligas
instead
first
evid
antivir
activ
find
protein
influenza
b
viru
bind
subsequ
work
mani
laboratori
shown
conjug
inhibit
wide
rang
virus
includ
influenza
b
viru
sindbi
viru
herp
murin
herpesviru
studi
util
andor
knockout
mice
show
viru
replic
enhanc
knockout
mice
compar
wildtyp
wt
mice
contrast
enhanc
replic
observ
sever
virus
specif
vesicular
stomat
viru
vsv
lymphocyt
choriomenig
viru
lcmv
indic
virus
inhibit
conjug
free
unconjug
also
antivir
role
protect
mice
consequ
chikungunya
viru
infect
downregul
pathogen
cytokin
respons
often
denot
cytokin
storm
free
also
report
inhibit
product
hiv
virion
ebola
vp
viruslik
particl
tissu
cultur
cell
focu
antivir
action
conjug
viral
countermeasur
conjug
discuss
possibl
antivir
role
free
identifi
target
modif
antivir
protein
conceiv
modif
one
antivir
protein
would
enhanc
antivir
activ
antivir
protein
might
also
includ
cellular
protein
particip
activ
ifn
transcript
consist
possibl
report
modif
interferon
regulatori
increas
stabil
antagon
ubiquitin
consequ
enhanc
transcript
activ
sendai
viru
infect
howev
also
report
conjug
opposit
effect
rigi
protein
cytoplasm
sensor
viral
rna
requir
ifn
induct
name
overal
level
rigi
protein
downregul
presenc
conjug
enzym
result
mef
cell
exhibit
increas
basal
virusinduc
mrna
level
consequ
clear
whether
modif
cellular
protein
contribut
antivir
action
conjug
contrast
modif
viral
protein
shown
occur
result
loss
function
first
viral
target
identifi
protein
influenza
viru
protein
multifunct
protein
express
influenza
virusinfect
cell
incorpor
viru
particl
protein
compris
ntermin
doublestrand
rna
dsrna
bind
domain
rbd
ctermin
effector
domain
ed
bind
sever
cellular
protein
transfect
assay
multipl
lysin
ks
protein
sever
influenza
viru
strain
modifi
howev
infect
cell
conjug
occur
larg
one
two
ks
cell
infect
either
two
influenza
viru
strain
conjug
occur
larg
k
posit
rbd
particip
least
two
crucial
function
bind
dsrna
bind
nuclear
local
nl
function
rbd
surprisingli
bind
site
dsrna
total
overlap
enabl
molecul
bind
rbd
time
consequ
modif
rbd
domain
longer
bound
wherea
dsrnabind
larg
retain
revers
genet
studi
establish
import
modif
protein
antiinfluenza
action
ifn
recombin
influenza
viru
express
protein
replac
r
show
increas
resist
ifn
pretreat
compar
wt
viru
interestingli
replac
r
protein
circul
influenza
virus
isol
suggest
virus
undergon
select
elimin
modif
protein
differ
ks
protein
modifi
cell
infect
influenza
apr
viru
specif
found
modif
either
ed
larg
respons
antivir
activ
conjug
contrast
conjug
appar
differ
influenza
viru
strain
site
modif
protein
consist
evid
function
vari
extent
viru
strain
hepat
c
viru
also
conjug
transfect
experi
conjug
yet
verifi
ifntreat
infect
cell
transfect
experi
show
conjug
target
newli
synthes
protein
major
ligas
associ
ribosom
subunit
polyribosom
modif
shown
occur
cotransl
consequ
viral
protein
constitut
major
newli
synthes
protein
infect
cell
viral
protein
would
predomin
target
viru
infect
result
also
suggest
conjug
would
exhibit
limit
specif
protein
target
probabl
limit
specif
k
residu
particular
protein
target
howev
influenza
virusinfect
cell
protein
predomin
viral
protein
target
limit
modif
viral
protein
although
multipl
ks
modifi
transfect
experi
conjug
predominantli
target
one
two
ks
infect
cell
therefor
like
unidentifi
control
mechan
infect
cell
impos
select
choic
viral
protein
target
k
residu
target
ifninduc
conjug
viral
protein
extrem
ineffici
less
total
target
protein
popul
conjug
viru
infect
propos
low
level
conjug
viral
protein
would
dominantneg
effect
function
unconjug
counterpart
viral
protein
function
oligom
infect
cell
testofprincipl
capsid
protein
human
papilomaviru
hpv
modifi
transfect
assay
result
modif
protein
like
multipl
k
residu
hpv
pseudovirion
gener
prepar
protein
show
threefold
decreas
infect
compar
pseudovirion
gener
unconjug
protein
effect
conjug
protein
discuss
show
dominantneg
effect
like
also
occur
ifntreat
infect
cell
protein
shown
function
least
part
oligom
infect
cell
conjug
protein
lead
loss
function
decreas
viru
product
ifntreat
cell
howev
definit
evid
domin
neg
model
yet
obtain
sever
virus
develop
countermeasur
andor
conjug
one
strategi
exemplifi
influenza
b
viru
vaccinia
viru
bind
viral
protein
protein
influenza
b
viru
first
viral
protein
identifi
interactor
interact
function
import
discuss
follow
section
protein
vaccinia
viru
also
shown
bind
cell
infect
recombin
vaccinia
viru
lack
gene
protein
conjug
increas
rel
wt
viru
suggest
protein
inhibit
conjug
protein
via
ctermin
domain
bind
albeit
rnadepend
manner
vaccinia
viru
show
signific
virul
knockout
mice
wherea
wt
viru
equal
virul
wt
knockout
mice
howev
ctermin
domain
protein
antivir
activ
includ
dsrna
bind
remain
establish
increas
conjug
associ
delet
directli
due
bind
rather
indirect
effect
eg
increas
ifn
induct
anoth
viral
countermeasur
conjug
virusencod
proteas
remov
conjug
protein
target
first
type
viral
proteas
identifi
nairovirus
negativestrand
rna
virus
arterivirus
positivestrand
rna
virus
contain
ovarian
tumor
otu
domain
previous
identifi
sever
cellular
protein
cellular
otucontain
protein
known
function
deubiquitin
enzym
contrast
viral
otudomaincontain
protein
eg
l
protein
crimean
congo
hemorrhag
fever
viru
cchfv
nairoviru
protein
equin
arter
viru
eav
cleav
ub
protein
sever
result
indic
viral
otu
domain
function
vivo
thu
express
full
length
l
protein
cchfv
cchfvl
otu
domain
antagon
antivir
activ
conjug
mous
model
infect
sindbi
viru
otu
domain
cchfvl
protein
eav
also
suppress
tumor
necrosi
induc
activ
nuclear
ubdepend
event
tissu
cultur
cell
result
indic
dual
substrat
specif
viral
otu
protein
provid
effici
way
counter
ubdepend
host
defens
howev
clear
cleav
activ
need
light
expect
suppress
ifn
induct
ubcleav
activ
viral
otu
domain
structur
basi
dual
specif
cchfvl
otu
domain
determin
analysi
crystal
structur
viral
otu
domain
complex
either
ub
figur
bind
ub
involv
ntermin
extens
viral
otu
found
cellular
otu
domain
ntermin
extens
togeth
short
helix
bind
fold
ub
ctermin
ubl
domain
bind
result
orient
ub
dramat
differ
orient
ub
complex
cellular
otu
domain
propos
differ
orient
may
exploit
design
small
molecul
specif
inhibit
viral
otu
function
without
interf
cellular
enzym
cleav
ub
protein
ctermin
ubl
domain
ub
also
interact
viral
otu
domain
hydrogenbond
network
allow
tighter
pack
viral
otu
domain
possibl
explain
twofold
higher
affin
viral
otu
domain
studi
also
identifi
specif
residu
viral
otu
requir
bind
either
ub
therebi
enabl
investig
gener
otu
variant
preferenti
function
ub
cleavag
viral
otu
variant
use
determin
rel
import
ubcleav
activ
viral
otu
ccfhv
infect
type
viral
proteas
cleav
ub
protein
exampl
papainlik
proteas
sever
acut
respiratori
syndrom
sar
coronaviru
structur
analysi
proteas
complex
either
ub
yet
carri
demonstr
wide
array
differ
virus
encod
proteas
cleav
ub
protein
highlight
import
proteas
combat
ifninduc
antivir
activ
bind
human
protein
influenza
b
viru
first
evid
antivir
function
pathway
protein
like
protein
influenza
viru
contain
ntermin
rbd
amino
acid
ctermin
ed
amino
acid
rbd
form
homodim
possess
dsrnabind
activ
contrast
ed
appear
share
similar
activ
ed
inde
dsrnabind
activ
rbd
littl
els
known
function
protein
identifi
yeast
twohybrid
screen
use
bait
bind
sequenc
map
amino
acid
includ
rbd
also
addit
amino
acid
interdomain
linker
region
refer
ntermin
domain
region
ntr
rbd
alon
suffici
bind
protein
influenza
viru
bind
demonstr
bind
function
share
influenza
viru
transfect
experi
show
express
protein
inhibit
conjug
induc
either
ifn
treatment
coexpress
enzym
protein
exhibit
speciesspecif
bind
bind
human
nonhuman
primat
inabl
protein
bind
mous
explain
influenza
b
viru
replic
inhibit
wt
mice
surprisingli
acid
hing
human
nonhuman
primat
differ
sequenc
hing
mammalian
speci
absolut
requir
bind
protein
figur
exampl
substitut
mous
hing
sequenc
qncse
human
hing
sequenc
dkcde
human
result
total
loss
bind
protein
first
exampl
influenza
b
viru
protein
exhibit
human
nonhuman
primat
specif
properti
thu
provid
one
explan
restrict
influenza
b
viru
human
protein
would
abl
protect
influenza
b
viru
antivir
effect
conjug
human
presum
nonhuman
primat
protect
would
possibl
mammalian
speci
indic
influenza
b
viru
would
expect
maintain
mammalian
speci
howev
influenza
b
viru
might
also
found
nonhuman
primat
possibl
yet
explor
known
whether
influenza
b
viru
protein
also
exhibit
humanspecif
properti
thu
contribut
restrict
influenza
b
viru
human
structur
basi
speciesspecif
bind
protein
reveal
crystal
structur
complex
human
figur
complex
heterotetram
homodim
interact
two
molecul
one
side
dimer
stoichiometri
observ
solut
establish
equilibrium
sediment
experi
crystal
structur
complex
first
two
residu
human
linker
region
interact
directli
residu
verifi
two
human
linker
residu
need
bind
protein
crystal
structur
verifi
two
bind
site
distinct
dsrnabind
site
bind
site
compris
residu
chain
homodim
specif
residu
rbd
one
chain
residu
interdomain
linker
region
chain
residu
rbd
residu
interdomain
linker
region
make
strong
contact
transfect
assay
show
fulllength
protein
contain
alanin
substitut
either
two
set
residu
bind
confirm
previou
result
rbd
interdomain
linker
requir
bind
addit
crystal
structur
reveal
make
littl
contact
ctermin
ubl
domain
contrast
interact
viral
otu
domain
essenti
contact
ntermin
ubl
ntermin
end
linker
sequenc
consequ
bind
would
expect
occlud
access
ctermin
ubl
domain
conjug
enzym
bind
lead
inhibit
conjug
observ
transfect
assay
one
possibl
bind
impos
structur
impedi
conjug
instead
lead
sequestr
nucleu
away
cytoplasm
polyribosom
conjug
like
occur
human
cell
transfect
plasmid
express
protein
also
influenza
b
virusinfect
human
cell
protein
reloc
essenti
cytoplasm
nucleu
sequestr
hypothesi
test
use
recombin
influenza
b
viru
express
protein
mutat
bind
site
mutant
viru
also
expect
reveal
step
influenza
b
viru
replic
affect
conjug
studi
summar
establish
ifninduc
conjug
inhibit
replic
mani
virus
current
evid
indic
inhibit
like
result
conjug
one
viral
protein
small
fraction
popul
viral
protein
ifntreat
cell
domin
neg
model
propos
viral
target
whose
function
infect
reli
oligom
format
howev
addit
experiment
evid
sever
viru
system
need
prove
hypothesi
transfect
experi
vast
major
protein
conjug
contrast
exemplifi
influenza
viru
protein
predomin
target
modif
ifntreat
infect
cell
one
two
k
residu
protein
appar
modifi
futur
challeng
identifi
control
mechan
infect
cell
lead
select
specif
viral
protein
target
k
residu
target
insight
concern
control
mechan
may
come
vitro
system
use
purifi
compon
carri
conjug
although
purifi
current
avail
purif
activ
ligas
accomplish
coupl
translat
vitro
system
probabl
need
function
eukaryot
ribosom
compon
translat
system
establish
vitro
system
may
difficult
endeavor
understand
molecular
basi
recognit
open
new
question
avenu
interplay
influenza
b
viru
pathway
crystal
structur
complex
ntr
protein
show
ctermin
ubl
domain
complex
would
expect
access
conjug
enzym
consequ
remain
determin
protein
block
antivir
activ
conjug
influenza
b
viru
virusinfect
cell
protein
bind
mous
current
avail
mous
strain
suitabl
model
system
studi
pathogenesi
influenza
b
viru
difficulti
could
like
overcom
gener
mous
human
gene
substitut
mous
gene
transfect
experi
shown
human
effici
conjug
target
protein
mous
conjug
enzym
includ
mous
instead
human
ligas
viru
countermeasur
antivir
activ
conjug
identifi
far
includ
viral
protein
bind
remov
protein
target
perhap
virus
inhibit
ifninduc
eg
vsv
lcmv
develop
similar
countermeasur
encod
viral
protein
target
compon
conjug
system
eg
conjug
enzym
futur
experi
establish
whether
case
final
emphas
discuss
mechan
free
exert
antivir
effect
import
area
research
remain
poorli
understood
align
sequenc
four
speci
human
rhesu
monkey
mous
dog
gener
ncbi
access
number
respect
amino
acid
hing
ntermin
ctermin
ubl
domain
enclos
red
box
dark
blue
shade
denot
amino
acid
conserv
four
molecul
lighter
blue
shade
denot
amino
acid
present
three
two
molecul
